BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24018863)

  • 1. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
    Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
    Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
    Zhang FL; Huang Q; Liu JY; Huang MD; Xue JP
    ChemMedChem; 2015 Feb; 10(2):312-20. PubMed ID: 25336150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
    Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
    ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monomeric photosensitizer for targeted cancer therapy.
    Liang R; Ma L; Zhang L; Li C; Liu W; Wei M; Yan D; Evans DG; Duan X
    Chem Commun (Camb); 2014 Dec; 50(95):14983-6. PubMed ID: 25327438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D; Lo PC
    J Control Release; 2018 Jul; 282():46-61. PubMed ID: 29673646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Molecular Therapeutic Agent for Targeted and Controlled Dual Chemo- and Photodynamic Therapy.
    Ha SYY; Zhou Y; Fong WP; Ng DKP
    J Med Chem; 2020 Aug; 63(15):8512-8523. PubMed ID: 32666798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-aggregated and tumour-associated macrophage-targeted photosensitiser for photodynamic therapy: a novel zinc(II) phthalocyanine containing octa-sulphonates.
    Li XS; Ke MR; Zhang MF; Tang QQ; Zheng BY; Huang JD
    Chem Commun (Camb); 2015 Mar; 51(22):4704-7. PubMed ID: 25692672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
    Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
    ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved photodynamic efficacy of thiophenyl sulfonated zinc phthalocyanine loaded in lipid nano-carriers for hepatocellular carcinoma cancer cells.
    Abdel Fadeel D; Al-Toukhy GM; Elsharif AM; Al-Jameel SS; Mohamed HH; Youssef TE
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():25-31. PubMed ID: 29870793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.
    Wan DH; Zheng BY; Ke MR; Duan JY; Zheng YQ; Yeh CK; Huang JD
    Chem Commun (Camb); 2017 Apr; 53(29):4112-4115. PubMed ID: 28349131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G; Chambrier I; Cook MJ; Russell DA
    Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy.
    Makhseed S; Machacek M; Alfadly W; Tuhl A; Vinodh M; Simunek T; Novakova V; Kubat P; Rudolf E; Zimcik P
    Chem Commun (Camb); 2013 Dec; 49(95):11149-51. PubMed ID: 24040651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy.
    Zhang FL; Song MR; Yuan GK; Ye HN; Tian Y; Huang MD; Xue JP; Zhang ZH; Liu JY
    J Med Chem; 2017 Aug; 60(15):6693-6703. PubMed ID: 28699738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
    da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
    Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
    Liu JY; Li J; Yuan X; Wang WM; Xue JP
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():341-343. PubMed ID: 26192694
    [No Abstract]   [Full Text] [Related]  

  • 18. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells.
    Kimani SG; Shmigol TA; Hammond S; Phillips JB; Bruce JI; MacRobert AJ; Malakhov MV; Golding JP
    Photochem Photobiol; 2013; 89(1):139-49. PubMed ID: 22803957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction.
    Machacek M; Cidlina A; Novakova V; Svec J; Rudolf E; Miletin M; Kučera R; Simunek T; Zimcik P
    J Med Chem; 2015 Feb; 58(4):1736-49. PubMed ID: 25599409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.
    Kucinska M; Skupin-Mrugalska P; Szczolko W; Sobotta L; Sciepura M; Tykarska E; Wierzchowski M; Teubert A; Fedoruk-Wyszomirska A; Wyszko E; Gdaniec M; Kaczmarek M; Goslinski T; Mielcarek J; Murias M
    J Med Chem; 2015 Mar; 58(5):2240-55. PubMed ID: 25700089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.